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Abstract
Low-intrinsic aerobic capacity is associated with increased risk for cardiovas-
cular and metabolic diseases and is a strong predictor of early mortality. The
effects of intrinsic aerobic capacity on the vascular response to insulin are lar-
gely unknown. We tested the hypothesis that rats selectively bred for a low
capacity to run (LCR) exhibit vascular dysfunction and impaired vascular
reactivity to insulin compared to high capacity running (HCR) rats. Mature
female LCR (n = 21) and HCR (n = 17) rats were maintained under seden-
tary conditions, and in vitro thoracic aortic vascular function was assessed.
LCR exhibited greater body mass (13%), body fat (35%), and subcutaneous,
perigonadal, and retroperitoneal adipose tissue mass, than HCR. During an
intraperitoneal glucose tolerance test, glucose area under the curve (AUC) was
not different but insulin AUC was 2-fold greater in LCR than HCR. Acetyl-
choline and insulin-stimulated aortic vasorelaxation was significantly greater
in LCR (65.2  3.8%, and 32.7  4.1%) than HCR (55.0  3.3%, and
16.7  2.8%). Inhibition of nitric oxide synthase (NOS) with L-NAME
entirely abolished insulin-mediated vasorelaxation in the aorta of LCR, with
no effect in HCR. LCR rats exhibited greater expression of Insulin Receptor
protein, lower Endothelin Receptor-A protein, a down-regulation of tran-
scripts for markers of immune cell infiltration (CD11C, CD4, and F4/80) and
up-regulation of pro-atherogenic inflammatory genes (VCAM-1 and MCP-1)
in the aorta wall. Contrary to our hypothesis, low-aerobic capacity was associ-
ated with enhanced aortic endothelial function and NO-mediated reactivity to
insulin, despite increased adiposity and evidence of whole body insulin resis-
tance.
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Aerobic capacity, independent of physical activity, is a
strong predictor of cardiovascular disease and overall
mortality (Blair et al. 1989a, 1989b; Chang and Froelicher
1994; Pate et al. 1995; Myers et al. 2002). Low-aerobic
capacity per se is associated with greater risk of death
than other more established risk factors including physical
inactivity, hypertension, smoking, and type 2 diabetes.
The inverse relationship between aerobic capacity (i.e.,
aerobic fitness) and cardiovascular disease and mortality
is observed in both men and women, and is not con-
founded by age or other risk factors. (Powell et al. 1987;
Haskell et al. 1992; Blair et al. 1995).
Insulin resistance is also a major independent cardio-
vascular disease risk factor and is associated with all-cause
mortality (Ford 2005; Cersosimo and DeFronzo 2006;
Reddy et al. 2010). Insulin resistance is characterized by a
blunted ability of peripheral tissues to regulate glucose
homeostasis in response to insulin. While endothelial dys-
function is considered a precursor of vascular disease, evi-
dence now indicates that vascular insulin resistance is also
a prominent component of hypertension, coronary artery
disease, and atherosclerosis (Reaven 1993). In healthy per-
sons, insulin has important cardiovascular actions, includ-
ing increased blood flow and capillary recruitment in
skeletal muscle (Muniyappa et al. 2007). Abnormalities in
vascular reactivity to insulin are present in obese, physi-
cally inactive, and type 2 diabetic humans and animals.
Impairments in vascular sensitivity to insulin with disease
contribute to reduced skeletal muscle glucose uptake by
limiting perfusion and thus delivery of glucose and insu-
lin (Laakso et al. 1992; Wallis et al. 2002; Kim et al. 2006;
Mikus et al. 2010, 2012; Martin et al. 2012). While
increased physical activity and exercise can improve the
vasomotor response to insulin in animals and humans
displaying a disease phenotype (Mikus et al. 2010, 2012;
Martin et al. 2012; Crissey et al. 2014), the role of intrin-
sic aerobic capacity, independent of regular exercise, is
relatively unknown.
In the absence of exercise training, genetic inheritance
putatively accounts for up to 60–70% of the variation in
intrinsic aerobic capacity in humans (Bouchard et al.
1986). Data from a novel rodent model developed by Koch
and Britton demonstrate that low-aerobic capacity can be
inherited, and leads to impaired metabolic health and risk
factors for cardiovascular disease, independent of chronic
exercise effects (Hussain et al. 2001; Koch and Britton
2001; Wisloff et al. 2005; Lessard et al. 2009). In this
model, rats were selectively bred for high- or low-treadmill
endurance running (performance on three-graded tread-
mill exercise tests) over several generations, resulting in
two strains of rats with ~30% difference in aerobic capaci-
ties (Wisloff et al. 2005). The sedentary low-capacity run-
ners (LCR) display cardiovascular risk factors consistent
with the metabolic syndrome including gains in visceral
adiposity, increased blood pressure, dyslipidemia, micro-
vascular endothelial dysfunction, and insulin resistance
(Wisloff et al. 2005; Noland et al. 2007; Thyfault et al.
2009; Naples et al. 2010). Similar to the higher life expec-
tancy and reduced disease and mortality risk observed in
humans with high-aerobic capacity (Kujala et al. 2001;
Aarnio et al. 2002), LCR have a 45% shorter median life-
span than the high-capacity running (HCR) animals (Koch
et al. 2011). Together, these data support the hypothesis
that low-aerobic capacity can underlie disease risks and
reduce longevity. Since, these contrasting aerobic capacities
occur in a sedentary, cage-activity-only condition (Hoydal
et al. 2007) an advantage of this model is that it is free
from the confounding influence of exercise training on aer-
obic capacity and disease risk (Wisloff et al. 2005; Bernal-
Mizrachi and Semenkovich, 2006). This polygenic model
of disease more accurately mimics the pathology of human
chronic metabolic disease(s) than single gene mutations,
making it an ideal model to study the interaction between
aerobic capacity, and chronic disease, independent of exer-
cise. Therefore, in this study, we set out to uncover the
influence of intrinsic (untrained) aerobic exercise capacity
on insulin-stimulated vasoreactivity, a marker of vascular
and metabolic health. Specifically, we tested the hypothesis
that inherited low-aerobic capacity in LCR rats is associ-
ated with vascular dysfunction and impaired vasorelax-
ation to insulin in the aorta.
Methods
Animals
Koch and Britton (Hussain et al. 2001; Koch and Britton
2001; Wisloff et al. 2005) originally developed two lines
of rats divergent in intrinsic aerobic endurance exercise
capacity. The founder population (N:NIH stock) and gen-
erations of the HCR and LCR rats have been previously
reported (Wisloff et al. 2005). Briefly, the 13 lowest and
13 highest running capacity rats of each sex were selected
from the founder population and randomly paired for
mating. By generation six, there was a 171% divergence
in running capacity, with most of the change in running
capacity relative to the founder population occurring in
the HCR line (13% in LCR and 136% in HCR) (Martin
et al. 2012). After 28 generations of selection, the HCR
and LCR lines differed about eightfold for the running
capacity phenotype and maintained considerable narrow-
sense heritability (h2) for this trait (HCR h2 = 0.47, and
LCR h2 = 0.43) (Ren et al. 2013). Genome-wide 10 K sin-
gle-nucleotide polymorphism (SNP) genotype data for
generations 5, 14, and 26 demonstrated substantial geno-
mic evolution as assessed by Multidimensional Scaling
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(MDS) analysis. That is, between-line differentiation
increased progressively, while within-line diversity
decreased. In the present investigation, we used female
LCR (n = 21) and HCR (n = 17) rats from generations
31 and 32, as body weight differences between phenotypes
are less marked in females than in males (Hussain et al.
2001), therefore, body weight was less likely to confound
our results. At 11 weeks of age, rats were phenotyped for
intrinsic endurance running capacity (intrinsic aerobic
capacity) by distance run to exhaustion on a motorized
treadmill using a velocity-ramped running protocol at the
University of Michigan (Hussain et al. 2001; Koch and
Britton 2001, 2005). Rats performed three treadmill exer-
cise trials, and the single best trial of three was used as
the indicator of aerobic capacity determined by intrinsic
genetic composition (Koch and Britton 2005). Following
this exercise test, all animals remained sedentary and
underwent no further exercise training or testing (sponta-
neous cage physical activity-only) to factor out the con-
founding influence of daily exercise. At 16 weeks of age,
the animals were shipped to the University of Missouri,
where they remained for the completion of the study.
Animals were housed in pairs maintained in a tempera-
ture (21°C) and light controlled, 12:12-hr light–dark cycle
(lights off at 1800 h) animal quarters, and provided ad lib-
itum access to water and standard rodent chow (Formu-
lab 5008, Purina Mills, St. Louis, MO) comprised of
~26% protein, 18% fat, and 56% carbohydrate. The Uni-
versity of Missouri Institutional Animal Care and Use
Committee approved all experimental protocols.
Intraperitoneal Glucose Tolerance Tests
Intraperitoneal glucose tolerance tests (IPGTT) were
performed at 39 weeks of age (n = 6 per group), as
previously described (Rector et al. 2011). Briefly, food
was removed from the cages 12 h before each rat received
an intraperitoneal injection of dextrose (50% solution,
2 g/kg body weight). Venipuncture blood samples were
collected from the lateral tail vein immediately before
(0 min) dextrose administration and 15, 30, 45, 60, and
120 min after injection. Insulin and glucose responses
were quantified by the product of the area under the
curve (AUC) for glucose and insulin using the trapezoidal
method (Tai 1994).
Body Composition and Blood Parameters
Following an overnight fast, we anesthetized the rats at
44 weeks of age with an intraperitoneal injection of
sodium pentobarbital (50 mg/kg). We measured body
mass of the rats and determined body composition by
using a dual energy X-ray absorptiometry machine
(Hologic QDR-1000) calibrated for rodents. Subsequently,
we harvested tissues, collected blood samples, and eutha-
nized the rats by exsanguination, in full compliance with
the American Veterinary Medical Association Guidelines
on Euthanasia. Serum samples were prepared by centrifu-
gation and stored at 80°C until analysis. Glucose, cho-
lesterol, triglycerides, and nonesterified fatty acids (NEFA)
assays were performed by a clinical diagnostic service pro-
vided by the University of Missouri (Comparative Clinical
Pathology Services LLC, Columbia, MO) on an Olympus
AU680 automated chemistry analyzer (Beckman-Coulter,
Brea, CA) using commercially available assays according
to the manufacturer’s guidelines. Plasma insulin concen-
trations were determined using a commercially available,
rat-specific ELISA (Alpco Diagnostics, Salem, NH). Sam-
ples were run in duplicate and manufacturer’s controls
and calibrators were used according to assay instructions.
The homeostasis model assessment-insulin resistance
(HOMA-IR) was calculated according to the formula of
Matthews et al. (Matthews et al. 1985): [fasting glucose
(mg/dL) • fasting insulin (lIU/mL)]/405).
Assessment of Aortic Vascular Function
Isolation and assessment of thoracic aortic ring function
was determined as previously described (Thompson et al.
2004; Ingram et al. 2007; Bunker et al. 2010). Briefly,
immediately following exsanguination we removed the
thoracic aorta and dissected and cleaned the vessel of con-
nective and adipose tissue in ice-cold Krebs-bicarbonate
buffer (4°C). The thoracic aorta was segmented into aortic
rings, and their outer diameter, inner diameter, and axial
length were measured with an Olympus microscope and
NIH ImageJ software. Aortic rings were mounted on myo-
graphs and submerged in 20-mL water baths containing
physiological Krebs solution maintained at 37°C for 1 h to
allow for equilibration. We determined the optimal vessel
diameter, which elicited a maximal response to 60 mM
KCL (Lmax); which was around 150% of the passive diame-
ter. Aortic vasoreactivity was assessed with cumulative
concentration-response curves to Acetylcholine (ACh,
1010 to 104 M), insulin (10–1000 lIU/mL), and sodium
nitroprusside (SNP, 1010 to 104 M). Mounted rings
were preconstricted with a submaximal concentration of
phenylephrine (PE, 3E7 M) prior to ACh, insulin and
SNP dose-response curves.
The vasoreactivity to insulin was assessed with human
insulin (Novolin, Novo Nordisk, Plainsboro, NJ) in
10-min intervals. We evaluated the contribution of
endothelin-1 (ET-1) and nitric oxide (NO) in the aortic
vasomotor response to ACh and insulin by incubating
separate aortic rings with tezosentan (3 lM), a nonselective
ETA and ETB receptor antagonist, or L-NG-Nitroarginine
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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methyl ester (L-NAME, 300 lM), a NO synthase (NOS)
inhibitor, for 20 min prior to ACh and insulin curves.
Following each drug dose-response curve, we washed the
vessel baths with warm Krebs-bicarbonate buffer (37°C)
and allowed a re-equilibration period of 30 min. For
ACh, insulin, and SNP curves, relaxation at each concen-
tration was measured and expressed as percent maximum
relaxation, where 100% relaxation is equivalent to loss of
all tension developed in response to phenylephrine (Bun-
ker et al. 2010).
RNA extraction and real-time PCR
We performed RNA extraction and real-time PCR on
thoracic aorta samples as previously described (Padilla
et al. 2013a,b,c; Crissey et al. 2014). Briefly, the thoracic
aortic was dissected and all connective and perivascular
adipose tissues were removed. The aortic samples were
homogenized in TRIzol solution using a tissue homoge-
nizer (TissueLyser LT, Qiagen, Valencia, CA). Total RNA
was isolated using the Qiagen’s RNeasy tissue protocol
and assayed using a Nanodrop spectrophotometer
(Thermo Scientific, Wilmington, DE) to assess purity and
concentration. First-strand cDNA was synthesized from
total RNA using the High Capacity cDNA Reverse Tran-
scription kit (Applied Biosystems, Carlsbad, CA). Quanti-
tative real-time PCR was performed as previously
described (Padilla et al. 2013a,b,c) using the CFX Con-
nectTM Real-Time PCR Detection System (BioRad, Hercu-
les, CA). Primer sequences (Table 1) were designed using
the NCBI Primer Design tool. All primers were purchased
from IDT (Coralville, IA). A 20-lL reaction mixture con-
taining 10 lL iTaq UniverSYBR Green SMX (BioRad,
Hercules, CA) and the appropriate concentrations of
gene-specific primers plus 4 lL of cDNA template were
loaded in each well of a 96-well plate. All PCR reactions
were performed in duplicate. PCR was performed with
thermal conditions as follows: 95°C for 10 min, followed
by 40 cycles of 95°C for 15 s and 60°C for 45 s. A disso-
ciation melt curve analysis was performed to verify the
specificity of the PCR products. 18S primers were used to
amplify the endogenous control product. Our group has
established that 18S is a suitable house-keeping gene for
real-time PCR when examining vascular gene expression
(Crissey et al. 2014) In this study, 18S CTs were not dif-
ferent among lines. Values of mRNA expression of mRNA
are presented as 2DCT whereby DCT = 18S CT  gene of
interest CT (Padilla et al. 2013a,b,c), and normalized to
the HCR group of rats, which was set at 1.0.
Immunoblots
The abdominal aorta was dissected and cleaned of all con-
nective and adipose tissue in ice-cold Krebs-bicarbonate
buffer, cut into segments, placed in Laemmli buffer
(62.5 mM Tris, pH 6.8, 6 M urea, 160 mM 1,4-dithiothrei-
tol, 2% SDS, and 0.0001% bromophenol blue), flash frozen
in liquid nitrogen, and stored at 80°C until analysis. Wes-
tern blotting to determine protein expression in the
abdominal aorta was performed as previously described
(Bunker et al. 2010; Mikus et al. 2010). Briefly, samples
were subjected to three cycles of boil-vortex-centrifugation
Table 1. Forward and reverse primer sequences for quantitative real-time PCR
Gene
Primer sequence (5 30)
Forward Reverse
18S GCCGCTAGAGGTGAAATTCTTG CATTCTTGGCAAATGCTTTCG
VCAM-1 GAAGGAAACTGGAGAAGACAATCC TGTACAAGTGGTCCACTTATTTCAATT
ICAM-1 CACAAGGGCTGTCACTGTTCA CCCTAGTCGGAAGATCGAAAGTC
MCP-1 CTGTCTCAGCCAGATGCAGTTAA AGCCGACTCATTGGGATCAT
IL-6 AGAGACTTCCAGCCAGTTGC AGCCTCCGACTTGTGAAGTG
IL-10 CTGGCTCAGCACTGCTATGT GCAGTTATTGTCACCCCGGA
TNF-a AACACACGAGACGCTGAAGT TCCAGTGAGTTCCGAAAGCC
ET-1 TTGCTCCTGCTCCTCCTTGAT TAGACCTAGAAGGGCTTCCTAGT
ENOS AGGCATCACCAGGAAGAAGA GGCCAGTCTCAGAGCCATAC
CD8 CACTAGGCTCCAGGTTTCCG CGCAGCACTTCGCATGTTAG
CD3e AGTAATGAGCCAGCCGTGTC ATGCTCCAGAAAGCGTTCCA
CD11c CTGTCATCAGCAGCCACGA ACTGTCCACACCGTTTCTCC
CD4 ACCCTAAGGTCTCTGACCCC TAGGCTGTGCGTGGAGAAAG
F4/80 GCCATAGCCACCTTCCTGTT ATAGCGCAAGCTGTCTGGTT
PAI-1 AGCTGGGCATGACTGACATCT GCTGCTCTTGGTCGGAAAGA
FoxP3 CTCCAGTACAGCCGGACAC GGTTGGGCATCAGGTTCTTG
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and sonication, and protein of was quantified with Nano-
Orange Protein Quantitation kits (Molecular Probes, Life
Technologies, Grand Island, NY). Samples were diluted in
Laemmli buffer, boiled for 5 min and equal amounts of
aortic proteins (10 lg) were loaded on NuPAGE Novex
4–12% Bis-Tris Protein Gels, 1.5 mm, 15 well gels (Life
Technologies) under reducing conditions. Proteins were
transferred to polyvinyldifluoride membrane (PVDF
Hybond-ECL, Amersham). Each gel contained one lane of
SeeBlue Plus 2 prestained protein standard (Life Technolo-
gies) to evaluate protein transfer and determine molecular
weight of the samples. We blocked the membrane for 1 hr
at room temperature with 5% nonfat milk in TBS-Tween
(20 mM Tris  HCl, 137 mM NaCl, and 0.1% Tween 20),
and incubated overnight at room temperature with a pri-
mary antibody against: Insulin Receptor-b (IRb, 1:200,
Santa Cruz Biotechnology, Dallas, TX); Endothelin-1
(ET-1, 1:200, Santa Cruz Biotechnology); Endothelin
Receptor-A (ETA, 1:200, Sigma, St. Louis, MO); Endothelin
Receptor-B (ETB, 1:250, Alamone Labs); eNOS (1:1000,
Transduction Labs); and phospho-specific eNOS (1:200,
Transduction Labs). Next, we incubated the membranes
with a corresponding horseradish peroxidase-conjugated
secondary antibody in a 5% nonfat milk-TBST solution.
Protein was detected by enhanced chemiluminescence (Lu-
minata Forte Western HRP Substrate, Millipore) and
imaged using a Kodak Image Station 4000R. Total and
phospho-specific densities were normalized to HCR values,
and the ratio of phospho-eNOS to total eNOS was calcu-
lated.
Drugs and Solutions
All drugs and solutions were obtained from Sigma
(St. Louis, MO), except albumin (USB Corporation, Cleve-
land, OH). The Krebs-bicarbonate buffer solution con-
tained (in mM) 131.5 NaCl, 5.0 KCl, 1.2 NaH2PO4, 1.2
MgCl2, 2.5 CaCl2, 11.2 glucose, 20.8 NaHCO3, 0.003
propranolol, and 0.025 EDTA. The solution was aerated
with a 95% O2 – 5% CO2 mixture (pH7.4) and maintained
at 37°C. All drug solutions were prepared in Krebs-bicar-
bonate buffer, except insulin, which was prepared fresh
daily in physiological saline solution with bovine serum
album (BSA, 1 g/100 mL). We also prepared SNP fresh
daily and protected the serial dilutions from light.
Data Analysis and Statistics
Results are presented as mean  SEM. We evaluated over-
all group effects (LCR vs. HCR) on all dependent variables
using two-tailed Student’s t-tests. We analyzed all drug
dose-response curves from vasomotor function experi-
ments by repeated measures two-way (group 9 dose) ANO-
VAs, and evaluated main effects of group, interactions
between group and dose, and simple effects. When appro-
priate, Fisher’s least significant differences (LSD) post hoc
analysis was utilized. We used IBM SPSS Statistics 19 for
Windows (Chicago, IL) for all statistical analyses, and
established a priori statistical significance of P < 0.05.
Results
Animal Characteristics and Glucose
Tolerance
After 32 generations of artificial selection for intrinsic aero-
bic capacity, HCR rats ran significantly farther distance
(+10-fold, P < 0.001), duration (+5-fold P < 0.001), and
at greater speed (+3-fold P < 0.001) compared to LCR rats
(Table 2) during the graded exercise tests to exhaustion,
performed at 11 weeks of age. For the remainder of the
study, the rats did not engage in any structured exercise
training or exercise bouts. LCR rats were ~13% heavier,
owing to ~35% greater percent body fat compared to HCR
animals determined by DEXA (Fig. 1A and B). The
increased adiposity in the LCR rats was evident by ~34%
more visceral (perigonadal and retroperitoneal) adipose
tissue than HCR rats (Fig. 1C). Although heart weight was
slightly different between lines (Fig. 1D), no differences
were observed when heart weight was normalized to body
weight (Fig. 1E). Fasting serum triglycerides, nonesterified
fatty acids, glucose, insulin, and HOMA-IR were all not
significantly different between LCR and HCR female rats at
44 weeks of age (Table 2, P > 0.05). Glucose responses
during the IPGTT were also not different between lines
(Fig. 2A and D); however, insulin secretion (Fig. 2B) and
Table 2. Animal characteristics
Variable LCR HCR
Max distance run to
exhaustion at 11 weeks (m)
238  8 2303  68*
Time to exhaustion at
11 weeks (min)
17.2  0.4 78.7  1.4*
Speed at exhaustion at
11 weeks (m/min)
18.1  0.2 48.8  0.7*
Triglycerides (mg dL1) 44.9  6.8 29.2  2.7
Nonesterified fatty acids
(mmol L1)
44.3  3.3 39.9  2.0
Glucose (mg dL1) 150  5 173  15
Insulin (ng dL1) 1.74  0.29 1.78  0.46
HOMA-IR index 0.67  0.11 0.87  0.33
Values are expressed as means  SEM.
*Denotes line difference (P < 0.05).
LCR, low-capacity runner; HCR, high-capacity running; HOMA-IR,
homeostasis model assessment of insulin resistance.
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insulin AUC (Fig. 2C) were greater in LCR animals sugges-
tive of modestly impaired insulin sensitivity.
Aortic Gene Expression
As shown in Fig. 3, LCR rats exhibited increased mRNA
expression of the chemoattractant molecules VCAM-1
and MCP-1 but reduced expression of inflammatory
genes CD11C, CD4, F4/80, and PAI-1 relative to HCR
(Fig. 3, all P < 0.05). The up-regulation of pro-athero-
genic/inflammatory chemoattractant genes may be sugges-
tive of an increased atherosclerosis risk within the aortic
wall of LCR.
Aortic Protein Expression
Immunoblot analysis presented in Figure 4A revealed
greater Insulin Receptor (IR) and lower Endothelin
Receptor-A (ETA) protein expression in the abdominal
aorta of LCR compared to HCR animals (P < 0.05).
However, we observed no differences in Endothelin-1
(ET-1) or Endothelin Receptor-B (ETB) protein expres-
sion between lines. Insulin induces vasocontraction by
ET-1 via either ETA or ETB receptors on vascular smooth
muscle, while activation of ETB receptors on endothelium
signals vasorelaxation through release of NO by the endo-
thelium (Kim et al. 2006). Thus, our results suggest that
a greater relative density of endothelial ETB receptors in
LCR, may have promoted greater vasorelaxation through
production of NO. Examination of the p-eNOS/eNOS
ratios (Fig. 4B) showed that, relative to the total pool of
available eNOS in the abdominal aorta, the percentage of
p-eNOS trended (P = 0.07) to be greater in LCR rats
compared with HCR rats.
Aortic Vasoreactivity
We observed no differences in vessel characteristics: outer
diameter, inner diameter, vessel length, or specific tension
(normalized to vessel surface area) elicited by 60 mM
KCl, and phenylephrine preconstriction between lines
(Table 3). Counter to our hypothesis endothelium depen-
dent dilation, assessed by acetylcholine (ACh)-induced
vasorelaxation in thoracic aortic rings was significantly
greater in LCR compared to HCR animals (Fig. 5A,
Group effect P < 0.05). The maximum aortic relaxation
to ACh was 55.0  3.3% in HCR, and 65.2  3.8%
in LCR rats. Similarly, insulin-stimulated aortic vasorelax-
ation was significantly greater in LCR than HCR
across all insulin doses (Fig. 5B, Group P = 0.003) with a
significant group 9 dose interaction (P = 0.03). Insulin
(1000 lIU/mL) induced approximately twofold higher
maximal vasorelaxation of the aorta in LCR (32.7  4.1%)
compared to HCR (16.7  2.8%). We did not observe any
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Figure 1. Body composition in low-capacity running (LCR), and high-capacity running (HCR) rats. AT, adipose tissue; SQ, subcutaneous
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differences in aortic vascular smooth muscle function, as
assessed by SNP-mediated relaxation (Fig. 5C).
Role of Endothelin-1 and Nitric Oxide in
Aortic Vasomotor Responses
ACh-induced aortic vasorelaxation was unaltered by ET-1
blockade, with tezosentan (Fig. 6A and C) in both lines.
In contrast, inhibition of NOS with L-NAME completely
blocked aortic ring relaxation responses to ACh in both
LCR and HCR animals, indicating that ACh-mediated va-
sorelaxation in the thoracic aorta is entirely NO mediated
(Fig. 6B and D), corresponding to previously reported
data in this animal model (Ritchie et al. 2013). Analogous
to ACh, ET-1 blockade (3 lM tezosentan) had no effect
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on insulin-stimulated relaxation in the aorta of LCR or
HCR animals (Fig. 7A and C), suggesting that insulin-
induced ET-1 release and/or ET-1-mediated contraction
does not account for differences in the vasomotor
response to insulin between lines. In contrast, inhibition
of NOS with L-NAME completely abolished insulin-medi-
ated vasorelaxation of the aorta in LCR animals (Fig. 7D),
with no effect in HCR rats (Fig. 7B). Importantly, these
data suggest that insulin-induced aortic relaxation of
HCR rats is not driven by mechanisms involving eNOS
generated NO, while insulin-stimulated vasorelaxation of
the aorta is entirely NO dependent in LCR rats.
Discussion
Evidence in humans indicates that low-aerobic capacity is
a strong predictor of early mortality (Blair et al. 1989a,
1989b; Myers et al. 2002) and is linked to cardiovascular
disease (Myers et al. 2002), yet the mechanism(s) are not
completely understood. In this study, we investigated the
relationship between intrinsic aerobic exercise capacity and
vascular insulin reactivity in a rodent model divergent in
endurance running capacity (LCR and HCR rats) known
to display differing metabolic profiles (Noland et al. 2007;
Lessard et al. 2009; Naples et al. 2010) by testing the
hypothesis that inherited low-aerobic capacity is associated
with vascular dysfunction and impaired vasorelaxation.
Our main findings include: (1) aortic endothelial depen-
dent vasorelaxation, assessed by ACh, was similar if not
greater in LCR compared to HCR rats; (2) insulin-stimu-
lated vasorelaxation of the aorta was greater in LCR com-
pared to HCR rats; (3) the contribution of NO in
mediating insulin-stimulated vasorelaxation was greater in
LCR compared to HCR rats; (4) the aorta of LCR rats dis-
played greater expression of IR protein and lower vasocon-
strictive ETA receptor protein; and (5) the aorta of LCR
rats exhibited increased mRNA expression of VCAM-1 and
MCP-1 but decreased mRNA for markers of immune cell
infiltration (i.e., decreased CD3, CD4, CD11C, F4/80).
We chose to assess the influence of intrinsic aerobic
capacity on endothelial function, because it has been
shown to be an independent predictor of long-term car-
diovascular disease progression and cardiovascular events
(Schachinger et al. 2000). To assess endothelial function
we examined acetylcholine (ACh)-induced vasorelaxation
in thoracic aortic ring segments isolated from LCR and
HCR rats. Counter to our hypothesis, and previous
reports of endothelial dysfunction in the carotid artery of
female LCR rats (Wisloff et al. 2005), our results indicate
Table 3. Vessel characteristics
Group
OD
(mm)
ID
(mm)
Length
(mm)
SA
(mm2)
Wall Thickness
(mm)
60 mM KCL
(g)
Pre-PE
(g)
LCR 1.74  0.02 1.34  0.02 2.43  0.04 0.97  0.03 0.20  0.01 5.0  0.2 4.1  0.1
HCR 1.75  0.02 1.39  0.02 2.50  0.05 0.90  0.03 0.18  0.01 5.2  0.2 4.2  0.1
Values are expressed as means  SEM.
LCR, low-capacity runner; HCR, high-capacity runner; OD, outer diameter of the aorta; ID, inner diameter of the aorta; SA, aorta surface area;
60 mM KCL, contraction tension in response to 60 mM potassium chloride; and Pre-PE, preconstriction tension produced by phenylephrine.
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that maximal ACh-induced vasorelaxation in the aorta
was similar and even slightly greater (10%) in LCR com-
pared to HCR animals. Analogous to our findings, Ritchie
et al. reported no differences in aortic ACh-induced va-
sorelaxation in HCR or LCR rats (Ritchie et al. 2013).
Moreover, the female LCR and HCR rats in the studies of
Wisloff et al., Ritchie et al., and our study varied in age
(ranging from 16 to 24 weeks (Wisloff et al. 2005);
35 weeks (Ritchie et al. 2013); and 44 weeks in our
study), a known modifier of endothelial function. Taken
together, these data suggest that the carotid artery may be
more susceptible to endothelial dysfunction than the aorta
in LCR rats, and that the age-related decline in endothe-
lial function appears to differ between lines. To our
knowledge, no comprehensive time course study has been
conducted to determine the effects of age on endothelial
function in these two lines of rats. Our results show that
aortic endothelial dependent NO-mediated vasorelaxation
is similar, if not greater in LCR than HCR rats.
Contrary to our primary hypothesis, low-aerobic capac-
ity was not associated with impaired insulin-stimulated
vasorelaxation of the aorta in LCR rats; we observed
greater aortic insulin-stimulated vasorelaxation in LCR
rats compared to HCR animals. Insulin’s cardiovascular
actions are complex and are thought to be balanced by
two primary endothelial insulin signaling pathways to
induce: (1) vasorelaxation via the endothelial nitric oxide
synthase (eNOS) pathway produce nitric oxide (NO)
(Clark et al. 2003; Vincent et al. 2003; Kim et al. 2006),
and (2) vasocontraction via mitogen-activated protein
kinase (MAPK) signaling to produce endothelin-1 (ET-1)
(Kim et al. 2006; Muniyappa and Quon 2007; Muniyappa
et al. 2007). Thus, we evaluated the roles of NO and ET-
1 in insulin-mediated aortic vasorelaxation. Remarkably,
inhibition of nitric oxide synthase (NOS) with L-NAME
entirely abolished insulin-mediated vasorelaxation in the
aorta of LCR animals, with no effect in HCR, suggesting
that low-aerobic capacity is associated with greater NO
reliance to stimulate insulin-induced aortic vasorelax-
ation. While insulin has been shown to increase eNOS
mRNA and protein expression and downstream NO pro-
duction in humans and rodents (Aljada and Dandona
2000; Kuboki et al. 2000; Fisslthaler et al. 2003), we did
not observe any significant differences in eNOS mRNA or
protein levels between LCR and HCR. Despite similar
eNOS levels, the ratio of phosphorylated eNOS to total
eNOS in the LCR aorta trended to be 37% greater than
HCR (Fig. 4B), suggesting that enhanced relative phos-
phorylation (activation) of eNOS in the aorta of LCR rats
may have contributed to greater NO production. Insulin-
stimulated ET-1 aortic contraction did not differ between
lines, suggesting that local vascular ET-1 release and/or
ET-1 mediated vasocontraction does not account for the
differences in the aortic vasomotor response to insulin in
LCR and HCR rats. Insulin-induced ET-1 vasocontraction
occurs through either ETA or ETB receptors on vascular
smooth muscle, while activation of ETB receptors on
endothelium signals vasodilation through release of NO
by the endothelium (Kim et al. 2006). While ET-1 and
ETB receptor protein expression was not different between
lines, ETA receptor expression was lower in the LCR aorta
wall. Together, these data suggest that LCR aorta has a
greater relative density of endothelial ETB receptors,
which may promote vasorelaxation through production
of NO. In summary our results suggest that vascular insu-
lin signaling in the LCR aorta may have greater reliance
on NO via both the eNOS and ET-1 pathways leading to
greater insulin-stimulated vasorelaxation.
Similar to our prior investigations LCR rats displayed
elevated insulin secretion during a glucose tolerance test
(Noland et al. 2007; Naples et al. 2010). We also found
greater insulin receptor (IR) protein expression, and a
trend for greater the relative activation of eNOS (p-
eNOS/total eNOS ratio) in the LCR aorta. Although insu-
lin has been shown to increase the expression of eNOS
mRNA and protein in human and animal vascular cells
(Aljada and Dandona 2000; Kuboki et al. 2000; Fisslthaler
et al. 2003), we did not observe differences in basal eNOS
mRNA or protein levels between LCR and HCR. Thus,
our results are consistent with the possibility that insulin-
stimulated expression of total or phosphyorylated eNOS
may be up-regulated in the LCR aorta. We did not per-
form insulin-stimulated experiments for immunoblot
analysis in this study. Overall our results suggest that
increased insulin-stimulated vasorelaxation in the aorta of
LCR rats may be the result of enhanced vascular insulin
sensitivity, via greater vascular IR, and altered vascular
insulin signaling pathways that modestly increased the rel-
ative phosphorylation of eNOS and NO production.
Alternatively, it is possible that the higher skeletal mus-
cle capillarity and mitochondrial content found in high-
aerobic capacity reduces the vascular reactivity to insulin
necessary to maintain metabolic peripheral insulin action.
That is, it is possible that the vascular actions of insulin
with high-aerobic capacity may be less important for
optimal delivery of insulin and glucose, due to the greater
absolute skeletal muscle perfusion and muscle insulin sen-
sitivity. In addition, it is possible that cage confinement
may induce more behavioral stress in the “bred to run”
HCR than LCR rats, which may have influenced vascular
function in our study; however, our results do not allow
us to evaluate this possibility.
Our finding that NOS inhibition did not affect insulin-
stimulated vasorelaxation in HCR rats is surprising given
current understanding of insulin’s vascular actions to eli-
cit vasorelaxation via NO (Clark et al. 2003; Vincent et al.
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2003; Kim et al. 2006). In addition to the endothelial
actions of insulin, insulin has been shown to promote va-
sorelaxation via direct actions in vascular smooth muscle
cells (Sowers 2004). The design of our study does not
allow us to determine the relative contribution of the
endothelium and smooth muscle in the vasoreactivity to
insulin in the aorta, hence we cannot rule out the influ-
ence of vascular smooth muscle to our results. Rather, we
deduce that the vascular actions of insulin in the aorta
are primarily endothelial effects based on prior data,
where we showed that that insulin-mediated vasorelax-
ation is completely abolished in the denuded rat aorta
(Padilla and Jenkins 2013). Our data indicate that ACh
and insulin-stimulated vasomotor relaxation in the LCR
aorta is entirely through eNOS-mediated mechanisms. In
accord with our findings, Ritchie et al. report that EDHF-
mediated ACh vasorelaxation is impaired in LCR, despite
intact NO-mediated relaxation (Ritchie et al. 2013).
Taken together, it seems possible that insulin’s ability to
stimulate PGI2 and EDHF pathways is reduced with low-
aerobic capacity, leading to a compensatory overactivation
of insulin-stimulated NO production. Unlike LCR, insu-
lin-induced vasomotor relaxation via NO-independent
mechanisms in the HCR aorta. Future work investigating
mechanisms of vascular insulin action in endothelial and
vascular smooth muscle cells in this model are warranted.
To further characterize the vascular phenotype in LCR
and HCR rats, we assessed markers of inflammation and
immune cell infiltration in the aortic wall. We assessed
CD11c, a marker of classically activated macrophages/
antigen presenting cells; CD3, a T lymphoycte marker;
CD4, a T helper cell marker; F4/80, a global macrophage
marker; and vascular adhesion molecules VCAM-1 and
MCP-1. Concomitant with a down-regulation of markers
of immune cell infiltration (CD11c, CD3, CD4, and F4/
80,) we observed an up-regulation of inflammatory genes
(VCAM-1 and MCP-1) in the aorta of LCR. The
enhanced expression of adhesion molecules along with
reduced immune infiltrates may represent an early snap-
shot of immune activation in the aorta wall, such that a
future time point might exhibit enhanced immune cell
infiltration in LCR. Overall, the expression pattern of
pro-inflammatory markers together with an anti-athero-
genic immune cell profile found with low-aerobic capacity
requires further investigation.
In summary, we provide evidence that selective breed-
ing for intrinsic aerobic capacity, in the absence of exer-
cise training, modulates vasomotor function and vascular
phenotype in the aorta of mature female rats. Counter to
our hypothesis, we found that LCR rats exhibit similar, if
not greater endothelial dependent NO-mediated vasore-
laxation compared to HCR rats, suggesting that reduced
endothelial function in the aorta is not always associated
with decreased aerobic capacity. Furthermore, low-aerobic
capacity was associated with greater NO-mediated aortic
insulin-stimulated vasorelaxation, a phenomenon that
appears to be compensatory. Remarkably, insulin-medi-
ated vasorelaxation in HCR rats was independent of NO,
suggesting that high-aerobic capacity is associated with a
redundancy in mechanisms driving insulin-mediated vas-
cular effects. In conclusion, contrary to our hypothesis,
we found that low-aerobic capacity was associated with
enhanced aortic endothelial function and NO-mediated
reactivity to insulin, despite increased adiposity and evi-
dence of whole body insulin resistance.
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